Inogen Change In Cash Over Time
| INGN Stock | USD 8.48 0.17 2.05% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Inogen Performance and Inogen Correlation. Inogen |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Change In Cash Analysis
Compare Inogen Inc and related stocks such as Neuropace, SurModics, and Pulmonx Corp Change In Cash Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | (38 K) | 22.6 M | (7.4 M) | (12.6 M) | 11.5 M | 12 M |
| SRDX | 15.6 M | (7.7 M) | (45 K) | 28 M | 12.1 M | (30.6 M) | (8.5 M) | 7.1 M | 6.7 M | 424 K | 368 K | (12.2 M) | 22.4 M | (5.3 M) | (5 M) |
| LUNG | 84.2 K | 84.2 K | 84.2 K | 84.2 K | (83 K) | 447.5 K | (422.6 K) | 607.7 K | (5.9 M) | 10.6 M | 217 M | (83.1 M) | (46.7 M) | (18.2 M) | (17.3 M) |
| APYX | (384.9 K) | 1.1 M | (718 K) | 3.8 M | (2.2 M) | 6.1 M | 2.7 M | (4.5 M) | 5.8 M | 42.2 M | (16.9 M) | (11 M) | (20.7 M) | 33.5 M | 35.1 M |
| CVRX | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 33.4 M | 83 M | (35.9 M) | (15.6 M) | (14.8 M) |
| OFIX | 14.9 M | 19.6 M | (2.2 M) | (569 K) | 7.9 M | 26.8 M | (24.1 M) | 41.6 M | (9 M) | (1.8 M) | 26.4 M | (9 M) | (37.1 M) | (12.9 M) | (12.3 M) |
| AORT | 3.8 M | (13.8 M) | (8.7 M) | 24.6 M | (4.3 M) | 4.2 M | 19.1 M | (16.7 M) | 1.5 M | (7.9 M) | 27.7 M | (6.9 M) | (15.7 M) | 19.6 M | 20.6 M |
| KIDS | 6.5 M | 6.5 M | 6.5 M | 6.5 M | 6.5 M | (2.7 M) | (2.3 M) | 41 M | 18.1 M | 11.3 M | (41.9 M) | (21.1 M) | 1.5 M | 22.6 M | 23.7 M |
| SGHT | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | (2.8 M) | 17 M | 40.3 M | 199.2 M | (75.7 M) | (46.9 M) | (44.5 M) |
| ITGR | (277 K) | 13.6 M | (16.2 M) | 15.2 M | 41.4 M | 5.7 M | (30.4 M) | (8 M) | (18.5 M) | (12 M) | 35.7 M | (31.3 M) | 6.4 M | (598 K) | (568.1 K) |
| SIBN | (10.8 M) | (10.8 M) | (10.8 M) | 6.8 M | 9.1 M | 2.7 M | 7.6 M | (5.5 M) | 2.7 M | (14.7 M) | 43.1 M | 9.8 M | (42.7 M) | 12.6 M | 13.2 M |
Inogen Inc and related stocks such as Neuropace, SurModics, and Pulmonx Corp Change In Cash description
My Equities
My Current Equities and Potential Positions
| Inogen Inc | INGN |
| Classification | Obamacare Repeal |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 8.48
Check out Inogen Performance and Inogen Correlation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Inogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.